← Open Payments lookup

NPI 1306886916: Open Payments

NPI 1306886916. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,196 in 82 payments from 12 companies in 2025. Trend: 2023 $1,456 · 2024 $2,364 · 2025 $1,196

Food & beverage: $1,196
CompanyPaymentsAmount
Collegium Pharmaceutical, Inc.32$461
Indivior Inc.30$342
Salix Pharmaceuticals, a division of Bausch Health US, LLC6$137
PFIZER INC.5$79
Saluda Medical Americas, Inc.2$52
Takeda Pharmaceuticals U.S.A., Inc.1$23
Virtus Pharmaceuticals LLC1$23
Axsome Therapeutics, Inc.1$22
Braeburn Inc.1$19
Otsuka America Pharmaceutical, Inc.1$16

Products named: Belbuca, SUBLOCADE, RELISTOR, NURTEC ODT, Evoke, TRINTELLIX, LEVORPHANOL TARTRATE, Auvelity.